Clinical and Molecular Characterization of ALG1-CDG

Authors

  • Radhika Dhamija Department of Neurology (Division of Pediatric Neurology), University of Virginia, Charlottesville, VA
  • Chelsea Chambers Department of Neurology (Division of Pediatric Neurology), University of Virginia, Charlottesville, VA

DOI:

https://doi.org/10.15844/pedneurbriefs-30-2-5

Keywords:

Asparagine-Linked Glycosylation Protein 1, CDG, Carbohydrate-Deficient Transferrin

Abstract

Investigators from the Human Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California and a large study group utilized a combination of exome sequencing, targeted gene panels, and Sanger sequencing to identify thirty-one pathogenic variants in thirty-nine affected individuals with ALG1-CDG from 32 families.

Published

2016-04-05

Issue

Section

Genetic Disorders